Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AKAN stock hub

Akanda Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AKANis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
14.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
AKAN
In the news

Latest news · AKAN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-60.9
P25 -105.6P50 -46.5P75 -3.1
ROIC-53.4
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AKAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
177
Groups with data
11
Currency
USD
Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001888014
Company name
Akanda Corp.
Country
Canada
Country code
US
Cusip
00971M700
Employees
46
Enterprise value
$12.3M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-03-15
Isin
CA00971M7008
Last refreshed
2026-05-10
Market cap
$14.4M
Market cap category
Nano-Cap
Price
$27
Price currency
USD
Rev Per Employee
18,188.35x
Sector
Healthcare
Sic
2833
Symbol
AKAN
Website
https://www.akandacorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-15.44%
EV/Sales
14.7x
FCF yield
-17.45%
P/B ratio
0.26x
P/S ratio
17.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
Gross margin
24.91%
Gross Profit
$208,382
Gross Profit Growth
520.44%
Net Income
$-2.2M
Net Income Growth Years
1%
Pretax Margin
-286.3%
Profit Margin
-266.31%
Profit Per Employee
$-48,438
ROA
-28.69
ROCE
-110.1
ROE
-60.86
ROIC
-53.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
-66.74%
Cagr3y
-83.29%
EPS Growth Years
1
Revenue Growth
183.67x
Revenue Growth Years
1x
Revenue Growth3 Y
122.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.1
Assets
$6.2M
Cash
$2.5M
Current Assets
$3.6M
Current Liabilities
$2.8M
Debt
$391,241
Debt Equity
$0.12
Equity
$3.3M
Interest Coverage
-66.71
Liabilities
$2.9M
Long Term Assets
$2.6M
Long Term Liabilities
$70,869
Net Cash
$2.1M
Net Cash By Market Cap
$14.78
Net Debt Equity
$-0.65
Tangible Book Value
$3.3M
Tangible Book Value Per Share
$102
WACC
82.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.25
Net Working Capital
$-1.5M
Quick ratio
0.89
Working Capital
$724,276
Working Capital Turnover
$-0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
1Y total return
-66.72%
200-day SMA
34.56
3Y total return
-99.53%
50-day SMA
9.78
50-day SMA vs 200-day SMA
50under200
All Time High
1,743,747.8
All Time High Change
-100%
All Time High Date
2022-03-15
All Time Low
2.3
All Time Low Change
1,076.47%
All Time Low Date
2026-03-26
ATR
9.14
Beta
14.6
Beta1y
4.62
Beta2y
3.12
Ch YTD
162.4
High
35.45
High52
209
High52 Date
2025-10-01
High52ch
-87.08%
Low
27
Low52
2.3
Low52 Date
2026-03-26
Low52ch
1,076.47%
Ma50ch
176.05%
Premarket Change Percent
-6.8
Premarket Price
$34.66
Premarket Volume
105,264
Price vs 200-day SMA
-21.87%
RSI
55.4
RSI Monthly
9.24
RSI Weekly
51.47
Sharpe ratio
0.45x
Sortino ratio
1.27
Tr YTD
162.4
Tr1m
746.26%
Tr1w
-52.71%
Tr3m
525%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-3.7M
Operating margin
-443.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
531,245%
Float Percent
99.41%
Net Borrowing
-1,847,956
Shares Insiders
0.59%
Shares Institutions
1.46%
Shares Out
534,418
Short Float
4.03%
Short Ratio
0.24
Short Shares
4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$-2.5M
Average Volume
6,566,779.15x
Bv Per Share
102
CAPEX
$-754,245
Ch1m
746.1
Ch1w
-52.71
Ch1y
-66.72
Ch3m
525
Ch3y
-99.53
Ch6m
-9.77
Change
-27.4%
Change From Open
-23.6
Close
37.19
Days Gap
-4.97
Depreciation Amortization
35,452
Dollar Volume
10,954,413
Earnings Date
2026-05-22
EBIT
$-3.7M
EBITDA
$-3.7M
EPS
$-82.88
F Score
3
FCF
$-2.5M
FCF EV Yield
-20.48x
FCF Per Share
$-4.71
Financing CF
-171,098
Fiscal Year End
December
Founded
2,021
Investing CF
-1,120,042
Ipr
575
Iprfo
-100
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2025-04-30
Last Report Date
2025-06-30
Last Split Date
2026-04-13
Last Split Type
Reverse
Last10k Filing Date
2025-04-30
Ma150
17.71
Ma150ch
52.46%
Ma20
19.14
Ma20ch
41.06%
Net CF
-3,502,447
Next Earnings Date
2026-05-22
Open
35.34
Optionable
No
Position In Range
0
Post Close
27
Postmarket Change Percent
6.63
Postmarket Price
$28.79
Ppne
2,647,794
Pre Close
37.19
Price Date
2026-05-08
Ptbv Ratio
4.37
Relative Volume
0.06x
Revenue
836,664x
Tr6m
-9.77%
Volume
405,719
Z Score
-14.28
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AKAN pay a dividend?

Capital-return profile for this ticker.

Performance

AKAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-66.7%
S&P 500 1Y: n/a
3Y total return
-99.5%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns AKAN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.5%
Float: +99.4% of shares outstanding
Insider ownership
+0.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+4.0%
0.2 days to cover
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

AKAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.4
Neutral momentum band
Price vs 200-day MA
-21.9%
50/200-day relationship not available
Beta (5Y)
14.60
More volatile than the market
Sharpe ratio
0.45
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AKAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AKAN stock rating?

Akanda Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AKAN analysis?

The full report lives at /stocks/AKAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AKAN?

The latest report frames AKAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AKAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.